Search Results - covid-19

4 Results

Sort By:

Swabseq Universal Pathogen Diagnostic Platform (Case No. 2026-121)

Summary: UCLA researchers in the Department of Computer Science have developed a next-generation universal pathogen diagnostic platform combining scalable genomic sequencing, simplified laboratory workflows, and integrated logistics infrastructure to enable rapid, low-cost, high-throughput infectious disease detection. Background: The rise of pathogen-specific...

Published: 7/23/2026 | Inventor(s): Eleazar Eskin, Valerie Arboleda, Chongyuan Luo, Taryn Jakub, Traci Toy

Keywords(s): AI-guided diagnostics, Assay, Computer-Aided Diagnosis, COVID-19, Diagnostic Markers & Platforms, diagnostic platforms, Diagnostic Test, diagnostics, Infectious Diseases, Infrastructure, Medical diagnostics, metagenomic diagnostic platform, Pathogen, platform technology, scalable platform

Category(s): Therapeutics > Infectious Diseases, Therapeutics > Infectious Diseases > COVID, Software & Algorithms > Digital Health, Software & Algorithms, Platforms > Diagnostic Platform Technologies, Platforms, Diagnostic Markers, Diagnostic Markers > Targets And Assays

Targeted Lentiviral Transduction of B-Cells With Desired B-Cell Receptor Specificity (UCLA Case No. 2023-237)

UCLA researchers in the Division of Hematology and Oncology in the Department of Medicine, have discovered novel lentiviral vectors that can be used for gene delivery to B-cells and for the development of neutralizing antibodies against viruses. BACKGROUND: Microbial tropism is a microbiology term that describes the types of animals (including human),...

Published: 7/20/2026 | Inventor(s): Koki Morizono

Keywords(s): B Cell, cell receptor, COVID-19, VIral entry, Virus

Category(s): Therapeutics > Immunology And Immunotherapy

NRF2 Agonist as Therapeutic Modality to Increase Antiviral Efficacy of Existing Antivirals Against Coronavirus Infections (UCLA Case No. 2022-325)

UCLA researchers in the School of Medicine’s department of Infectious Disease have identified a novel therapeutic approach that can supplement existing FDA approved treatments for SARS-CoV2-2 infections to provide robust treatments against morbidity. BACKGROUND: The World Health Organization reports that as of June 2023, there have been over...

Published: 7/20/2026 | Inventor(s): Theodoros Kelesidis

Keywords(s): Coronavirus, COVID-19, Paxlovid, SARS-CoV-2, Viral Medication

Category(s): Therapeutics > Infectious Diseases

A Ferrobotic Swarm Technology for Accessible, Adaptable, and Automated Testing (Case No. 2023-021)

Summary: UCLA Researchers in the Department of Electrical and Computer Engineering have developed an automated, algorithm-driven nucleic acid amplification test (NAAT) method that is easy to manufacture, distribute, and yields accurate results with reduced demand of testing reagents. Background: Major epidemics over the last two decades have emerged...

Published: 7/20/2026 | Inventor(s): Dino Di Carlo, Sam Emaminejad, Haisong Lin, Wenzhuo Yu, Kiarash AmirMozafariSabet

Keywords(s): Algorithm, algorithm-based testing, automated testing, Automation, Cell Counting/Imaging, COVID-19, Ferrofluid, ferrorobotics, high throughput testing, Nanotechnology, nucleic acid amplification test (NAAT), Nucleic Acid Platform Systems, Nucleic Acids, polymerase chain reaction (PCR), pooling, Software & Algorithms, viral testing

Category(s): Software & Algorithms, Life Science Research Tools, Life Science Research Tools > Research Methods, Electrical > Electronics & Semiconductors, Diagnostic Markers, Life Science Research Tools > Cell Counting And Imaging, Platforms > Diagnostic Platform Technologies